Sustainability-related Initiatives and Memberships
SHIONOGI actively participates in sustainability-related initiatives. By expressing its commitment to the principles and goals advocated by these initiatives, SHIONOGI is working to transform its management practices and business operations.
|| Support of the United Nations Global Compact
Shionogi supports the United Nations Global Compact (UNGC), a global initiative to realize sustainable growth in the international community.
The UNGC is one of the global initiatives of the United Nations, encouraging corporations and various organizations to act as good citizens of society and participate in such initiatives to realize sustainable growth by showing responsible and creative leadership.
With the vision “Building Innovation Platforms to Shape the Future of Healthcare” as specified in the Medium-term Business Plan STS2030 Revision, Shionogi focuses on the solution of social issues. Furthermore, Shionogi will promote its initiatives for the continued fulfillment of responsibilities as a global citizen on a global scale as well as the realization of sustainable growth through business by supporting and implementing the 10 principles of the UNGC.
The UNGC is one of the global initiatives of the United Nations, encouraging corporations and various organizations to act as good citizens of society and participate in such initiatives to realize sustainable growth by showing responsible and creative leadership. The UNGC was officially launched in New York City in July 2000 and Kofi Annan announced the addition of the tenth principle against corruption in June 2004, during the first Global Compact Leaders Summit.
As of March 2024, over 24,000 organizations from 167 countries signed UNGC and organize activities with 10 principles-based approach in 4 areas (human rights, labor, the environment and anti-corruption).
Human Rights
Principle 1: Businesses should support and respect the protection of internationally proclaimed human rights; and
Principle 2: make sure that they are not complicit in human rights abuses.
Labour
Principle 3: Businesses should uphold the freedom of association and the effective recognition of the right to collective bargaining;
Principle 4: the elimination of all forms of forced and compulsory labour;
Principle 5: the effective abolition of child labour; and
Principle 6: the elimination of discrimination in respect of employment and occupation.
Environment
Principle 7: Businesses should support a precautionary approach to environmental challenges;
Principle 8: undertake initiatives to promote greater environmental responsibility; and
Principle 9: encourage the development and diffusion of environmentally friendly technologies.
Anti-Corruption
Principle 10: Businesses should work against corruption in all its forms, including extortion and bribery.
|| Antimicrobial resistance (AMR) engagement initiatives
The AMR Industry Alliance is made up of private companies working together to offer sustainable solutions to combat AMR. Over 100 research and development-focused pharmaceutical companies, generic drug companies, biotechnology companies, diagnostic drug companies, and various associations are involved. SHIONOGI has been engaged in this initiative since its inception, being one of the 12 companies that signed the "AMR Industry Roadmap" at the Davos Conference in September 2016, which led to the formation of the AMR Industry Alliance.
|| Pharmaceutical supply chain engagement initiatives（PSCI）
We are happy to announce that SHIONOGI joined in the Pharmaceutical Supply Chain Initiative (PSCI) in August, 2017. The PSCI is a non profit organization which promotes of the sustainable procurement in the pharmaceutical and healthcare industry. The number of PSCI member companies is on the increase and more than 50 companies join in the PSCI now. The basic principles adopted under the PSCI cover a comprehensive range of fields, including not only environment and health and safety but also human rights and labor, ethics, and their associated management systems. In 2020, the principles were revised, and further items added. SHIONOGI will continue to support the revised principles and strongly urge all suppliers to endorse them throughout the value chain.
|| General Environmental Engagement Initiatives
■ Environment
The Eco-First Program aimed at enhancing efforts by the business sector to tackle environmental challenges. Under this program, the Minister of the Environment, Japan certifies companies those are demonstrating "advanced, unique, and industry-leading business initiatives" as "Eco-First companies".
SHIONOGI is the inaugural pharmaceutical company to receive the "Eco-First company" certification. Additionally, SHIONOGI is a member of the Eco-First Promotion Council, comprised of companies that have been certified as Eco-First companies.
The environmental committee of the federation of pharmaceutical manufacturers' association of Japan informs member organizations about environmental issues and measures within the pharmaceutical industry. SHIONOGI is a member of the voluntary action plan for the creation of a recycling-based society working group, a sub-organization of the environmental committee.
SHIONOGI participates in the environmental issue committee of the Japan pharmaceutical manufacturers association, which is comprised of research and development-focused pharmaceutical companies, as well as the carbon neutral group, a sub-organization of the environmental issue committee, to conduct discussions on addressing challenges in the pharmaceutical industry related to the environment.
■ Climate Change
The SBTi is an international collaboration that assists companies in establishing science-based greenhouse gas reduction targets to align with the Paris Agreement's goal of limiting global average temperature increase to 1.5°C above pre-industrial levels. SHIONOGI has set SBT as its greenhouse gas emission reduction target for fiscal year 2030, with the aim of achieving carbon neutrality by 2050. In June 2021, SHIONOGI was certified by the SBTi.
In 2022, SHIONOGI announced its support for the Task Force on Climate-related Financial Disclosures (TCFD) recommendations and became a member of the TCFD Consortium. We have developed a climate change strategy based on the TCFD framework and shared it on our website.
JH2A is an organization dedicated to addressing the challenges of integrating hydrogen, a clean energy source, into society and fostering a hydrogen economy that is sustainable for both people and the environment. SHIONOGI has been a member of JH2A since 2023 and is actively involved in its initiatives.
■ Biodiversity
The "30by30 target" aims to protect or conserve at least 30% of land and sea areas as healthy ecosystems by 2030. In September 2023, SHIONOGI endorsed the target's mission to "advance efforts towards meeting the international target of the 30by30 target" and joined the "30by30 Alliance for Biodiversity," a voluntary initiative involving companies, local governments, and organizations.
The Japan Business Federation (Keidanren) is committed to promoting and implementing the Keidanren Declaration for Biodiversity and Guidelines to achieve a society of coexistence with nature and a sustainable economic society. They have also declared their commitment to contributing to the achievement of global goals such as the GBF (Kunming-Montreal Biodiversity Framework), SDGs, as well as Japan's national strategy including 30by30. SHIONOGI has endorsed the Declaration of Biodiversity by Keidanren and Action Policy (Revised Edition) and has announced its environmental policy for the future and specific examples of environmental initiatives through the Keidanren Initiative for Biodiversity Conservation.
|| General Social Engagement Initiatives
SHIONOGI has been participating in the Health and Productivity Management Alliance since 2024. The Health and Productivity Management Alliance is an organization of over 300 companies and organizations with the mission of "revitalizing Japanese companies and realizing the sustainability of health insurance through employee health." We are working on three initiatives: study groups and seminars, health and productivity management assessments based on questionnaires and data analysis, and building an information platform for health and productivity management solutions.
Through our participation in this alliance, we will further promote and enhance our health and productivity management efforts by using best practices across industries as a reference for SHIONOGI's efforts and by disseminating the efforts of the SHIONOGI Group.
For more information about the Health and Productivity Management Alliance, please click here.
Membership
The SHIONOGI Group promotes initiatives not only through its own activities but also by working to address various challenges facing the pharmaceutical industry. Through participation in a wide range of industry organizations, the Group contributes to improving issues related to healthcare both in Japan and globally, including quality control, safety enhancement, improved access to medicines, and measures to combat counterfeit drugs, thereby supporting the sound development of the pharmaceutical industry.
The SHIONOGI Group is a member of the following organizations:
・International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
・Japan Pharmaceutical Manufacturers Association (JPMA Federation)
・Japan Pharmaceutical Manufacturers Association (JPMA)
・Kansai Pharmaceutical Manufacturers Association (KPMA)
The Shionogi Group positions promotion of diversity and inclusion as one of the important human resource strategies of the entire Group. We agree with activities of “The Valuable 500” which is a global initiative promoting disability inclusion, and joined it in the current fiscal year. The Valuable 500 is a global campaign that was launched at the World Economic Forum (Davos Meeting) in January 2019. We will further enhance employees’ engagement (willingness to contribute towards the company philosophy and accomplishment of their objectives) by building the working environment where Shionogi colleagues can perform their full potential as members of the Shionogi Group regardless of presence or absence of disability. Thereby, Shionogi will make continued effort to contribute to establishment of an including society where each one of us can show our value.
